Sands Capital Life Sciences Pulse Fund-GP, L.P. — Form D/A
Sands Capital Life Sciences Pulse Fund-GP, L.P. of ARLINGTON, VA, a pooled investment fund, filed a Form D amendment with the SEC on 2020-07-07. $1.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-07-07
- Form: D/A
- Accession: 0001781279-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $1.1M
- Investors: 18
- Date of first sale: 2019-06-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-343519
Issuer
- Name: Sands Capital Life Sciences Pulse Fund-GP, L.P.
- CIK: 0001781279
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: C/O SANDS CAPITAL VENTURES, LLC, ARLINGTON, VA, 22209
- Phone: 703-562-4000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jonathan Goodman | Executive Officer | Arlington, VA |
| Erin Soule | Executive Officer | Arlington, VA |
| JOB TAYLOR | Executive Officer | ARLINGTON, VA |
| STEPHEN ZACHARY | Executive Officer | ARLINGTON, VA |
Other filings by this issuer (1)
More